Sign in to view content

Higher-Order Optical Coherence Tomography Fluid Burden Assessment: Analysis From the OSPREY Trial

Justis P. Ehlers, MD, FASRS

Video
Published 2019

Justis Ehlers, MD

AMD Neovascular Part II Symposium

Related

96-Week Visual and Expanded Anatomical Outcomes of Brolucizumab Versus Aflibercept in Patients With nAMD: Results From HAWK and HARRIER
Chirag D. Jhaveri, MD, FASRS
Annual Meeting Talks
2019
FIDO Study: 10-Year Outcomes of Eyes Receiving Continuous, Fixed-Interval Dosing of Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
Ivan J. Suner, MD, MBA
Annual Meeting Talks
2019
Interview Reversal of Retinal Ischemia After Anti-VEGF Therapy
Thomas R. Friberg, MD
Updates from the Field
2019

Category: AMD-Neovascular

See more